Cambridge Nutritional Sciences PLC
LSE:CNSL
Relative Value
The Relative Value of one
CNSL
stock under the Base Case scenario is
1.62
GBX.
Compared to the current market price of 2 GBX,
Cambridge Nutritional Sciences PLC
is
Overvalued by 19%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
CNSL Competitors Multiples
Cambridge Nutritional Sciences PLC Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Cambridge Nutritional Sciences PLC
LSE:CNSL
|
4.8m GBP | 0.6 | 3.5 | 13.6 | -2.3 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.1T JPY | 9.9 | 36.4 | 26.3 | 31.5 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.5B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.3B CHF | 3.8 | 37.4 | 15.4 | 30.1 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
120.8B DKK | 4.3 | 33.2 | 15.3 | 18.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.8B USD | 3.2 | 33.8 | 15.4 | 19.5 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.7 | 29.7 | 13.2 | 21.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.9B CNY | 9.4 | 26 | 23.5 | 23.5 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD | 1.2 | -19.2 | 19.3 | 91 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4.1B CHF | 5.1 | 20.7 | 13.4 | 18.2 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.2T KRW | 89.4 | -32.8 | -76 | -71.9 |